SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 151 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2017. The put-call ratio across all filers is 1.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $110,000 | -5.2% | 64,994 | -2.7% | 0.00% | -100.0% |
| Q2 2018 | $116,000 | +31.8% | 66,794 | +38.3% | 0.00% | 0.0% |
| Q1 2018 | $88,000 | -15.4% | 48,289 | +3.9% | 0.00% | 0.0% |
| Q4 2017 | $104,000 | -10.3% | 46,489 | +16.3% | 0.00% | 0.0% |
| Q3 2017 | $116,000 | -18.3% | 39,989 | +24.9% | 0.00% | 0.0% |
| Q2 2017 | $142,000 | +8.4% | 32,018 | +13.9% | 0.00% | 0.0% |
| Q1 2017 | $131,000 | -34.2% | 28,118 | -13.8% | 0.00% | -50.0% |
| Q4 2016 | $199,000 | +82.6% | 32,618 | +64.4% | 0.00% | +100.0% |
| Q3 2016 | $109,000 | +45.3% | 19,838 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $75,000 | -10.7% | 19,838 | -35.0% | 0.00% | 0.0% |
| Q1 2016 | $84,000 | – | 30,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |